Scandinavian Medical Solutions A/S (CPH:SMSMED)
3.070
+0.010 (0.33%)
Jul 28, 2026, 4:48 PM CET
CPH:SMSMED Balance Sheet
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 1.45 | 2.15 | 11 | 7.92 | 27.76 | 25.4 |
Cash & Short-Term Investments | 1.45 | 2.15 | 11 | 7.92 | 27.76 | 25.4 |
Cash Growth | -32.57% | -80.46% | 38.89% | -71.48% | 9.30% | 138.24% |
Accounts Receivable | 16.58 | 22.72 | 21.16 | 14.97 | 6.93 | 1.05 |
Other Receivables | 3.43 | 4.39 | 3.01 | 5.92 | 1.49 | 1.42 |
Total Trade Receivables | 27.26 | 29.92 | 25.57 | 21.25 | 8.73 | 2.81 |
Inventory | 100.68 | 109.74 | 84.58 | 85.93 | 56.18 | 16.13 |
Other Current Assets | 7.26 | 2.82 | 1.4 | 0.36 | 0.31 | 0.35 |
Total Current Assets | 129.39 | 141.81 | 121.15 | 115.1 | 92.67 | 44.35 |
Net Property, Plant & Equipment | 65.86 | 62.64 | 51.85 | 48.27 | 13.15 | 0 |
Other Long-Term Assets | 1.43 | 1.41 | 1.11 | 0.6 | 0.31 | 0.3 |
Total Assets | 196.67 | 205.86 | 174.12 | 163.96 | 106.13 | 44.64 |
Accounts Payable | 24.89 | 49.81 | 40.6 | 33.68 | 25.36 | 7.34 |
Current Portion of Leases | 8.77 | 6.62 | 4.03 | 3.45 | 0 | - |
Unearned Revenue | 21.63 | 4.58 | 7.71 | 16.53 | 11.83 | 8.95 |
Other Current Liabilities | 3.33 | 3.45 | 3.13 | 10.7 | 6.3 | 4.24 |
Total Current Liabilities | 88.77 | 91.03 | 77.33 | 71.82 | 40.33 | 20.53 |
Long-Term Debt | 30.16 | 26.56 | 21.86 | 7.46 | 0.11 | - |
Long-Term Leases | - | 30.34 | 13.35 | 17.69 | 0 | - |
Other Long-Term Liabilities | - | 1.83 | 0.95 | 0 | 0.34 | 0 |
Total Long-Term Liabilities | 35.06 | 30.34 | 13.35 | 17.69 | 3.27 | 0 |
Total Liabilities | 123.83 | 121.37 | 90.69 | 89.51 | 43.6 | 20.53 |
Common Stock | 1.11 | 1.11 | 1.1 | 1.09 | 1.09 | 0.85 |
Accumulated Other Comprehensive Income | -0.08 | -0.09 | 0 | 0 | - | - |
Retained Earnings | 71.81 | 81.65 | 81.38 | 73.36 | 61.1 | 23.26 |
Shareholders' Equity | 72.85 | 82.67 | 82.48 | 74.45 | 62.19 | 24.11 |
Total Liabilities & Equity | 196.67 | 205.86 | 174.12 | 163.96 | 106.13 | 44.64 |
Total Debt | 38.92 | 63.53 | 39.24 | 28.6 | 0.11 | 0 |
Net Cash (Debt) | -37.47 | -61.38 | -28.25 | -20.69 | 27.66 | 25.4 |
Net Cash Growth | - | - | - | - | 8.88% | 140.25% |
Net Cash Per Share | -1.35 | -2.22 | -1.03 | -0.76 | 1.04 | 7.68 |
Book Value | 72.85 | 82.67 | 82.48 | 74.45 | 62.19 | 24.11 |
Book Value Per Share | 2.63 | 2.99 | 3.00 | 2.73 | 2.33 | 7.29 |
Tangible Book Value | 72.85 | 82.67 | 82.48 | 74.45 | 62.19 | 24.11 |
Tangible Book Value Per Share | 2.63 | 2.99 | 3.00 | 2.73 | 2.33 | 7.29 |